Article Text

PDF
THU0032 Selective, Autoantibody-Immune Complex Mediated Proportional and Functional Changes of Specific NK-Cell Subsets in Early Seropositive but not Seronegative Rheumatoid Arthritis
  1. P. Chalan1,
  2. E. Brouwer1,
  3. J. Bijzet1,
  4. B.-J. Kroesen2,
  5. M. Boots1
  1. 1Department of Rheumatology and Clinical Immunology
  2. 2Department of Medical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Abstract

Background Despite substantial data demonstrating NK-cell impairment in rheumatoid arthritis (RA), the exact role of NK-cells in RA immunopathogenesis remains unclear.

Objectives We studied the involvement of CD56dim and CD56bright NK-cells in the early stages of RA development to elucidate their role in the pathogenesis of RA.

Methods The study included newly diagnosed RA patients and seropositive arthralgia patients (SAP), representing subjects at risk of progression to RA. Whole blood samples obtained from disease modifying anti rheumatic drug (DMARD)-free RA patients at the time of diagnosis (autoantibody -positive [SP RA, n=45] and -negative [SN RA, n=12]); SAP (n=30) and healthy controls (HC, n=41), were studied to assess absolute numbers and proportions of T-cells, B-cells and NK-cells. Peripheral blood mononuclear cells (PBMC) were used for both phenotypical and functional analyses of NK-cells in the studied groups.

Results Patients (SP RA and SAP) positive for anti-cyclic citrullinated protein antibodies (ACPA) and/or rheumatoid factor (RF) showed decreased total NK-cell numbers. Also, NK-cells from SP RA showed a decreased potency for IFN-γ production. NK-cell subset analysis demonstrated a specific decrease of CD56dim, but not CD56bright NK-cells in SP RA and SAP. Differential NK-cell alterations in seropositive and seronegative patients prompted the investigation of the role of CD16 (FcγRIIIa) triggering in apoptosis induction and cytokine expression by CD56dim and CD56bright NK-cell subsets. CD16 triggering in vitro induced apoptosis of CD56dim, but not CD56bright NK-cells, and was augmented by the addition of IL-2. Also, CD16 triggering in the presence of IL-2 stimulated IFN-γ expression by CD56dim NK-cells.

Conclusions The decline of CD56dim NK-cells is an early feature in the development of seropositive, but not seronegative RA. The decline of CD56dim NK-cells in SAP and SP RA and observed in vitro apoptosis of CD56dim NK-cells upon CD16 triggering, suggests a functional role of IgG-containing autoantibody (ACPA and/or RF)-immune complexes in CD16-mediated apoptosis. Moreover, CD16 triggering leads to an increased cytokine response by CD56dim NK-cells, which may contribute to the proinflammatory state in both SP RA and SAP.

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.